Effects of celecoxib versus ibuprofen on craving in opioid abusers during withdrawal period
Not Applicable
- Conditions
- Craving.Mental and behavioural disorders due to use of opioids withdrawal state
- Registration Number
- IRCT201609207202N11
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Age range 18-65; not using other NSAIDs during the trial; having abused opiates for at least six months
Exclusion criteria: pregnancy; lactation; suffering serious physical illnesses such as cancer, cardiovascular diseases, respiratory, cerebrovascular diseases and any thyroid disorder including Hypo or hyperthyroidism; People with other axis I psychiatric disorders and intellectual disability.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Craving. Timepoint: At baseline and 4 weeks after the initiation of the study. Method of measurement: Drug Desire Questionnaire (DDQ).
- Secondary Outcome Measures
Name Time Method Pain. Timepoint: At baseline and 4 weeks after the initiation of the study. Method of measurement: 0-10 numeric pain rating scale.;Other side effects of treatments. Timepoint: after 4 weeks of treatment. Method of measurement: Side Effect Check List.